Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Vitamin D  COVID-19 treatment studies for Vitamin D  C19 studies: Vitamin D  Vitamin D   Select treatmentSelect treatmentTreatmentsTreatments
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta
Lactoferrin Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
COVID-19 mortality is associated with low Vitamin D levels in patients with risk factors and/or advanced age
Jenei et al., Clinical Nutrition ESPEN, doi:10.1016/j.clnesp.2021.11.025
Jenei et al., COVID-19 mortality is associated with low Vitamin D levels in patients with risk factors and/or advanced age, Clinical Nutrition ESPEN, doi:10.1016/j.clnesp.2021.11.025
Nov 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Retrospective 257 hospitalized patients in Hungary, showing mortality associated with lower vitamin D levels for all patients, for patients >60, and for age-matched patients with risk factors or age >60. The non-age-matched analyses are confounded by age, with elderly patients more likely to have lower vitamin D levels.
Jenei et al., 24 Nov 2021, peer-reviewed, 10 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin DAll
Abstract: Journal Pre-proof COVID-19 mortality is associated with low Vitamin D levels in patients with risk factors and/or advanced age Tímea Jenei, Sándor Jenei, László T. Tamás, Ákos Putics, Márta Knausz, Irén Hegedüs, Imre Dinnyés, Zsuzsanna Szalai, Tamás F. Molnár, Béla Büki PII: S2405-4577(21)01129-3 DOI: https://doi.org/10.1016/j.clnesp.2021.11.025 Reference: CLNESP 1209 To appear in: Clinical Nutrition ESPEN Received Date: 17 November 2021 Accepted Date: 17 November 2021 Please cite this article as: Jenei T, Jenei S, Tamás LT, Putics Á, Knausz M, Hegedüs I, Dinnyés I, Szalai Z, Molnár TF, Büki B, COVID-19 mortality is associated with low Vitamin D levels in patients with risk factors and/or advanced age, Clinical Nutrition ESPEN, https://doi.org/10.1016/j.clnesp.2021.11.025. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2021 The Author(s). Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism. 1 COVID-19 mortality is associated with low Vitamin D levels in patients with risk factors and/or advanced age ro DINNYÉS6, Zsuzsanna SZALAI ¹, Tamás F. MOLNÁR⁷,⁸, Béla BÜKI⁹ of Tímea JENEI ¹, Sándor JENEI ², László T. TAMÁS ³, Ákos PUTICS ⁴, Márta KNAUSZ ⁴, Irén HEGEDÜS ⁵ , Imre lP re -p (Family names in capital letters) ¹Department of Pulmonology, Petz Aladár University Teaching Hospital, 2-4. Vasvári Pál u., 9023 Győr, Hungary na E-mail: drjeneitimea@gmail.com; drszalaizs@gmail.com Jo Pécs, Hungary ur ²Department of Informatics, Institute of Matematics and Informatics, University of Pécs, 6. Ifjúság u., 7624 E-mail: jenei@ttk.pte.hu ³ Department of Otorhinolaryngology, Petz Aladár University Teaching Hospital, 2-4. Vasvári Pál u., 9023 Győr, Hungary E-mail: ltamas@gyor.net ⁴Department of Microbiology Petz Aladár University Teaching Hospital, 2-4. Vasvári Pál u., 9023 Győr, Hungary E-mail: akos.putics@gmail.com; drknauszmarta@gmail.com ⁵ Department of Infectology, Petz Aladár University Teaching Hospital, 2-4. Vasvári Pál u., 9023 Győr, Hungary E-mail: hegedus.iren.dr@gmail.com ⁶Department of Laboratory, Petz Aladár University Teaching Hospital, 2-4. Vasvári Pál u., 9023 Győr, Hungary E-mail: dinnyesimre@gmail.com 2 ⁷ Department of Operational Medicine, Faculty of Medicine, University of Pécs, 12. Szigeti u., 7624 Pécs, Hungary; ⁸St. Sebastian Thoracic Surgery Unit, Department of Surgery, Petz Aladár University Teaching Hospital, 2-4. Vasvári Pál u., 9023 Győr, Hungary E-mail: tfmolnar@gmail.com ⁹Department of Otorhinolaryngology, University Hospital Krems, Karl Landsteiner University of Health Sciences, Mitterweg 10, A-3500 Krems an der Donau, Austria -p ro of E-mail: bela.bueki@krems.lknoe.at re Corrsponding author Béla Büki, M.D., Ph.D., lP Department of Otolaryngology, Karl Landsteiner University Hospital Krems, Mitterweg 10, A-3500 Krems an der Donau, Austria; ur Abstract na E-mail: bela.bueki@krems.lknoe.at Jo BACKGROUND & AIMS Although..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit